{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:00:35Z","timestamp":1777971635585,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.rbmo.2019.02.005","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T02:50:52Z","timestamp":1551235852000},"page":"149-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Early prediction of the success of methotrexate treatment success by 24\u2013hour pretreatment increment in HCG and day 1\u20134 change in HCG"],"prefix":"10.1016","volume":"39","author":[{"given":"Gabriel","family":"Levin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uri","family":"Dior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Shushan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronit","family":"Gilad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi","family":"Benshushan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amihai","family":"Rottenstreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2019.02.005_bib0001","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1097\/AOG.0000000000002560","article-title":"Tubal Ectopic Pregnancy","volume":"131","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0002","first-page":"46","article-title":"Ectopic pregnancy\u2013United States, 1990-1992","volume":"44","year":"1995","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0003","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.fertnstert.2006.11.138","article-title":"Prognostic value of human chorionic gonadotropin changes after methotrexate injection for ectopic pregnancy","volume":"88","author":"Agostini","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0004","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.fertnstert.2010.09.006","article-title":"Pregnancy of unknown location: a consensus statement of nomenclature, definitions, and outcome","volume":"95","author":"Barnhart","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMcp0810384","article-title":"Clinical practice. Ectopic pregnancy","volume":"361","author":"Barnhart","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rbmo.2019.02.005_bib0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5152\/jtgga.2013.50133","article-title":"Assessment of early decline in the percentage of \u03b2-hCG values between days 0 and 4 after methotrexate therapy in ectopic pregnancy for the prediction of treatment success","volume":"14","author":"Celik","year":"2013","journal-title":"J. Turk. Ger. Gynecol. Assoc."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejogrb.2017.02.007","article-title":"The role of HCG increment in the 48h prior to methotrexate treatment as a predictor for treatment success","volume":"211","author":"Cohen","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0008","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/AOG.0b013e3182113c10","article-title":"Trends in ectopic pregnancy mortality in the United States: 1980-2007","volume":"117","author":"Creanga","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0009","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00404-008-0589-4","article-title":"Increment in beta-hCG in the 48-h period prior to treatment: a new variable predictive of therapeutic success in the treatment of ectopic pregnancy with methotrexate","volume":"278","author":"da Costa Soares","year":"2008","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5001\/omj.2011.24","article-title":"Methotrexate treatment of ectopic pregnancy: experience at nizwa hospital with literature review","volume":"26","author":"Dhar","year":"2011","journal-title":"Oman Med. J."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0011","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejogrb.2017.06.020","article-title":"Role of day 4 HCG as an early predictor of success after methotrexate therapy for ectopic pregnancies","volume":"215","author":"Girija","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0012","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/humrep\/del433","article-title":"A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy","volume":"22","author":"Kirk","year":"2007","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0013","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ijgo.12633","article-title":"The predictive role of serum hCG 0-4 days after methotrexate treatment for ectopic pregnancy is yet to be determined","volume":"143","author":"Levin","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0014","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ijgo.12395","article-title":"Predicting success of methotrexate treatment by pretreatment HCG level and 24-hour HCG increment","volume":"141","author":"Levin","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejogrb.2016.07.489","article-title":"Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF","volume":"205","author":"Marret","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0016","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.fertnstert.2006.10.007","article-title":"Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review","volume":"87","author":"Menon","year":"2007","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.03.022","article-title":"Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy?","volume":"202","author":"Nguyen","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0018","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2393-13-30","article-title":"Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study","volume":"13","author":"Skubisz","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.rbmo.2019.02.005_bib0019","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1471-0528.2011.03133.x","article-title":"Decline in \u03b2hCG levels between days 0 and 4 after a single dose of methotrexate for ectopic pregnancy predicts treatment success: a retrospective cohort study","volume":"118","author":"Skubisz","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.rbmo.2019.02.005_bib0020","first-page":"332","article-title":"Single-dose versus two-dose administration of methotrexate for the treatment of ectopic pregnancy: a randomized controlled trial","volume":"31","author":"Song","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0021","first-page":"204","article-title":"An economic evaluation of single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured ectopic pregnancy","volume":"108","author":"Sowter","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.rbmo.2019.02.005_bib0022","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/0002-9378(93)90687-E","article-title":"Single-dose methotrexate: an expanded clinical trial","volume":"168","author":"Stovall","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0023","first-page":"754","article-title":"Single-dose methotrexate for treatment of ectopic pregnancy","volume":"77","author":"Stovall","year":"1991","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0024","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0015-0282(16)46349-1","article-title":"Treatment of interstitial ectopic pregnancy with methotrexate: report of a successful case","volume":"37","author":"Tanaka","year":"1982","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2393-12-98","article-title":"Has increased clinical experience with methotrexate reduced the direct costs of medical management of ectopic pregnancy compared to surgery?","volume":"12","author":"Westaby","year":"2012","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.rbmo.2019.02.005_bib0026","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ijgo.12419","article-title":"Trends in serum human chorionic gonadotropin levels 0-4 days after methotrexate administration for predicting tubal ectopic pregnancy treatment success","volume":"141","author":"Wong","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.rbmo.2019.02.005_bib0027","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.rbmo.2017.01.004","article-title":"Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis","volume":"34","author":"Yang","year":"2017","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.rbmo.2019.02.005_bib0028","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1021106032198","article-title":"Surveillance in a time of changing health care practices: estimating ectopic pregnancy incidence in the United States","volume":"6","author":"Zane","year":"2002","journal-title":"Matern. Child Health J."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319301026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648319301026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T16:46:32Z","timestamp":1573577192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648319301026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1472648319301026"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.02.005","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early prediction of the success of methotrexate treatment success by 24\u2013hour pretreatment increment in HCG and day 1\u20134 change in HCG","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2019.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}